| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 20,184 | 6,055 | 6,055 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| MARKETABLE SECURITIES | 325,703 | 365,679 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| LEGACY VENTURE V (QP), LLC | AT COST | 498,835 | 693,268 |
| LEGACY VENTURE IX, LLC | AT COST | 863,299 | 1,439,723 |
| MINERVA BIOTECH | AT COST | 356,164 | 356,164 |
| Description | Amount |
|---|---|
| MINERVA BIOTECH - WARRANTS | 319,000 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FILING FEES | 510 | 0 | 0 | |
| OFFICE EXPENSE | 3,814 | 1,144 | 1,144 | |
| OTHER DEDUCTIONS FROM PASSTHROUGHS | 35,409 | 35,409 | 0 | |
| BANK FEES | 30 | 15 | 15 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| FEDERAL REFUND | 1,389 | 0 | 1,389 |
| LEGACY IX | 20 | 20 | 20 |
| LEGACY IX | 1,503 | 1,503 | 1,503 |
| LEGACY V | 53 | 53 | 53 |
| STATE REFUND | 485 | 485 | 485 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| DUE TO DLMC INC | 0 | 38 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOUNDATION GOVERNANCE | 9,726 | 0 | 0 | |
| HOOVER | 4,163 | 0 | 4,163 | |
| BEST PRACTICES | 16,810 | 0 | 0 | |
| PHILANTHROPY RESEARCH | 35,969 | 0 | 35,969 | |
| INVESTMENT RESEARCH | 10,826 | 10,826 | 0 | |
| HCAC | 1,012 | 0 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES PAID FROM PASSTHROUGHS | 338 | 338 | 0 | |
| FOREIGN TAXES PAID - SCHWAB | 26 | 26 | 0 | |
| FEDERAL TAXES PAID | 5,200 | 0 | 0 |